New Data on BRCA Mutations and Prophylactic Surgeries
A Diverse Vegetable Diet May Decrease Lung Cancer Risk for Smokers
Experts Weigh in on BRCA1/2 Mutations and Prophylactic Surgeries
The Relevant Distinction Between “Progression” in Ovarian Cancer Drug Trials and the Clinical Decision to Change Therapy
Experimental Therapeutics for Patients With Myeloproliferative Neoplasias
The Role of Epigenetic Transcription Repression and DNA Methyltransferases in Cancer
Intolerance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Surgical Treatment of Breast Cancer Among the Elderly in the United States
Stability of estrogen receptor status in breast carcinoma #
Effectiveness of Population-Based Service Screening With Mammography for Women Ages 40 to 49 Years
PDX-1
Overexpression of Receptor Tyrosine Kinase Axl Promotes Tumor Cell Invasion and Survival in Pancreatic Ductal Adenocarcinoma
Association of Multi-Drug Resistance Gene Polymorphisms With Pancreatic Cancer Outcome
Gemcitabine and Docetaxel in Metastatic, Castrate-Resistant Prostate Cancer #
Phase 1 Dose-Escalation Trial of Tremelimumab Plus Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Prognostic Model for Survival in Patients With Early Stage Cervical Cancer
Ovarian Cancer Care for the Underserved: Are Surgical Patterns of Care Different in a Public Hospital Setting? #
Trichostatin A Restores Apaf-1 Function in Chemoresistant Ovarian Cancer Cells
A Phase 2 Study of Pemetrexed Plus Gemcitabine Every 2 Weeks for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer
Long-Term Outcomes of Microsurgical Reconstruction for Large Tracheal Defects #
Biomarker-Based Phase I Dose-Escalation, Pharmacokinetic, and Pharmacodynamic Study of Oral Apricoxib in Combination With Erlotinib in Advanced Nonsmall Cell Lung Cancer #
Association of Diffuse, Random Pulmonary Metastases, Including Miliary Metastases, With Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma
A Phase 2 Trial of Imatinib Mesylate in Patients With Recurrent Nonresectable Chondrosarcomas Expressing Platelet-Derived Growth Factor Receptor-α or -β
Reporting Time-to-Event Endpoints and Response Rates in 4 Decades of Randomized Controlled Trials in Advanced Colorectal Cancer
Short Duration of Sleep Increases Risk of Colorectal Adenoma
Marijuana Use and Testicular Germ Cell Tumors
Structural and Reliability Analysis of a Patient Satisfaction With Cancer-Related Care Measure
Low Triglyceride and Nonuse of Statins is Associated With Cancer in Type 2 Diabetes Mellitus # *
Bladder Cancer and BCG Response Prediction
Reply to Bladder Cancer and BCG Response Prediction: What We Must Know?
Intra-Arterial Chemotherapy for Head and Neck Cancer
Reply to Intra-Arterial Chemotherapy for Head and Neck Cancer
Radiofrequency Ablation as an Adjunct to Systemic Chemotherapy for Colorectal Pulmonary Metastases
Reply to Radiofrequency Ablation as an Adjunct to Systemic Chemotherapy for Colorectal Pulmonary Metastases
Erratum: Policy Implications of Early Onset Breast Cancer Among Mexican-Origin Women